logo
PG&E tried to restart a battery plant over Monterey County officials' objections. It lasted less than a day

PG&E tried to restart a battery plant over Monterey County officials' objections. It lasted less than a day

When a massive fire ignited in January at one of the world's largest lithium-ion battery storage facilities, the neighbors demanded answers. They wanted to know what started the fire that smoldered for days, spewing toxic gas into the air and prompting evacuation warnings for 1,500 people.
Nearly five months later and with the fire's cause still unknown, Pacific Gas & Electric began reopening an adjacent battery site on Sunday, despite objections from local officials.
But the restart — which the utility company said was needed in order to meet summer energy demands — was called off almost as soon as it began.
On Sunday, workers who 'began methodically returning the batteries to service' discovered 'a clamp failure and coolant leak' in a Tesla Megapack battery unit on site, PG&E spokesman Paul Doherty said in a statement Monday.
'Out of an abundance of caution we are deferring the facility's return to service until a later date,' Doherty said.
The situation in Moss Landing highlights some of the underlying tensions of California becoming more reliant upon renewable energy, electric vehicles and battery-powered devices.
State officials have aggressively pushed to reduce greenhouse gas emissions by switching to clean energy sources. But the Vistra blaze has prompted calls for additional safety regulations around battery storage — as well as more local control over where storage sites are located.
The Elkhorn facility — which is owned by PG&E and maintained by both the utility company and Tesla — is one of two adjacent battery energy storage systems at the Moss Landing power complex near Monterey Bay. The other is owned by Texas-based Vistra Corp. The batteries store excess energy generated during the day and release it into the power grid during times of high demand, including evening hours.
Both facilities have been offline since Jan. 16, when a Vistra-owned building containing 99,000 LG battery modules caught fire.
The Elkhorn site includes 256 stationary Tesla Megapacks — essentially shipping container-sized units filled with battery modules. The facility did not burn but automatically shut down when its safety equipment detected the fire in the Vistra building.
PG&E announced last month that it planned to restart the Elkhorn facility by June 1 because, during the summer, 'that power is necessary to effectively manage the demands of the California power grid.'
Tesla and the utility company, two PG&E vice presidents wrote in a letter to the county supervisors, 'performed extensive inspection and clean-up' at the Elkhorn site.
After the discovery of problems at the Elkhorn facility Sunday, Monterey County Supervisor Glenn Church, whose district includes Moss Landing, called it 'a good sign' that PG&E quickly paused the restart. But, he said, he still wants the utility company to wait until the fire investigations are complete to try again.
'That PG&E encountered problems as they recharged their batteries points out the volatility of this technology,' Church told The Times in an email Monday night.
In a survey of nearby residents conducted by the Monterey and Santa Cruz county health departments, 83% of respondents said they experienced at least one symptom — most commonly headaches, sore throats and coughing — shortly after the fire.
Nearly a quarter of respondents said they had trouble breathing, and 39% reported having a metallic taste in their mouth.
The survey, conducted in February and March, was completed by 1,539 people who lived or worked in the region at the time of the fire. The results were released Monday.
Jim says, 'Always tell the truth and you never have to remember what you said.'Lisa says, ''Things always look better in the morning.' My dad was a realistic pessimist so this was solid advice coming from him and, over the years, it's proved to be true in my own life.'
Email us at essentialcalifornia@latimes.com, and your response might appear in the newsletter this week.
Today's great photo is from Times photographer Gina Ferazzi at a Riverside track field with Abi, a transgender high school athlete who navigates a fight she never asked for.
Hailey Branson-Potts, staff writerKevinisha Walker, multiplatform editorAndrew Campa, Sunday writerKarim Doumar, head of newsletters
How can we make this newsletter more useful? Send comments to essentialcalifornia@latimes.com. Check our top stories, topics and the latest articles on latimes.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Texas probes M&M maker Mars' resistance to removing synthetic dyes
Texas probes M&M maker Mars' resistance to removing synthetic dyes

Yahoo

time23 minutes ago

  • Yahoo

Texas probes M&M maker Mars' resistance to removing synthetic dyes

By Jonathan Stempel (Reuters) -Texas' attorney general said on Wednesday he has begun investigating Mars, which makes M&M's and Skittles candies, for its alleged refusal to remove synthetic food dyes from its products. Ken Paxton, the attorney general, said in a statement that he issued a civil investigative demand for documents from Mars, as he examines whether the family-owned company violated consumers' rights through deceptive trade practices. Paxton said Mars has not fulfilled its 2016 pledge to remove all artificial colors from food products, saying it had removed "toxic" dyes in Europe but not the United States. "It's time for Mars to follow the lead of other companies like Nestle and Hershey by removing synthetic dyes from its products," Paxton said. "It's the right thing to do." Mars, based in McLean, Virginia, had no immediate comment. Removing synthetic food dyes and reducing Americans' consumption of ultraprocessed foods has been a priority for U.S. Health and Human Services Secretary Robert F. Kennedy Jr, as part of his "Make America Healthy Again" campaign. Kennedy has blamed the dyes for health problems including attention deficit hyperactivity disorder and cancer, though many scientists say more research is needed. General Mills, J.M. Smucker, Kraft Heinz and PepsiCo, as well as Hershey and Nestle, are among companies that have committed to removing the dyes by 2028 or earlier. Mars has said its consumers have different attitudes toward artificial colors in food depending on where they live, with European consumers preferring the dyes removed while other consumers prefer to keep them.

Nanochon Announces Health Canada Approval for First in Human Investigation
Nanochon Announces Health Canada Approval for First in Human Investigation

Business Wire

time24 minutes ago

  • Business Wire

Nanochon Announces Health Canada Approval for First in Human Investigation

WASHINGTON--(BUSINESS WIRE)--Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating articular cartilage defects in the knee, is thrilled to announce that it was granted Health Canada Approval for their first in human clinical trial. The trial will be led by Principal Investigator, Dr. Fathi Abuzgaya, who will collaborate with Sports Medicine Specialists, Drs. Joel Lobo, Kajeandra Ravichandiran and Marcin Kowalczuk as Sub-Investigators, at the Durham Bone & Joint Specialists (DBJS), located in Ontario, Canada. Dr. Fathi Abuzgaya is an orthopedic surgeon by training and an esteemed researcher with a track record over the last 25 years, leading +600 clinical trials in all phases and therapeutic areas. 'Our team is delighted that we are the first center to start enrolling participants for the Chondrograft™ study, which represents a novel, minimally invasive treatment for patients with loss of or damaged knee cartilage,' Dr. Abuzgaya commented. 'DBJS is a multidisciplinary musculoskeletal center providing non-operative and operative treatments with accessibility to a variety of sub-specialties. Our study site with dedicated researchers enables greater, more efficient patient recruitment for clinical research and we are privileged to support Nanochon.' The Nanochon Chondrograft™ System is being evaluated in a prospective, 10 patient, early feasibility study for use in knee cartilage restoration in eligible patients between 22 and 60 years of age having femoral condyle and /or trochlea articular cartilage lesions who have failed conservative therapy, in addition to meeting other criteria. The study is designed to assess the safety and performance of Chondrograft™, and procedural goals include regrowth of the cartilage-bone matrix, improvement in knee function and pain, and delayed need for arthroplasty. 'Achieving Health Canada approval allows us to gain the clinical data needed to take a giant step forward towards design and execution of a large pivotal North American study,' said Ben Holmes, CEO of Nanochon. 'We have the utmost confidence in Dr. Abuzgaya and his clinical team at DBJS to help us recruit the right patients and execute the trial protocol that we have so carefully designed.' While the first in human trial will take place in Canada, this represents just the first step towards a larger clinical program. 'Thousands of patients with chondral defects, that may evolve to osteoarthritis, live with a reduced quality of life. We are looking forward to the potential for a new treatment option and are excited to begin the Chondrograft™ study at DBJS,' states Dr. Joel Lobo. 'The results of this study could open up a new surgical option, that is minimally invasive to address this unmet clinical need.' Throughout the clinical trial design and regulatory approval process, Nanochon was supported by HN Clinical Consulting (Missouri). "Improving the lives of young adults and athletes by providing a solution to restore knee cartilage and hopefully help patients avoid costly knee replacement is a crucial therapy needed in the orthopedic world," said Heather Neill, Founder and Principal. "We appreciate Health Canada's thought-provoking questions throughout their review that helped us put forward the strongest application possible, which ultimately led to our approval.' HN Clinical Consulting will continue to support the full life cycle of Chondrograft™. About HN Clinical Consulting HN Clinical Consulting, LLC, brings a strategic focus to each project, keeping the goal of commercialization in sight. Building strong relationships with all stakeholders and maintaining a clinical strategic goal of project-oriented success to support long term Sponsor strategy/exit is key to development of clinical programs. The objective set is to stay ahead by planning for podium presence, publication, and reimbursement while designing the Clinical Investigational Plan. About Nanochon Nanochon is a biotech and medical device company focused on developing innovative orthopedic solutions. Chondrograft™ is a minimally-invasive 3D printed implant that has allowed for immediate weight-bearing and motion in pre-clinical studies. The implant is based on research from the Tissue Engineering and Nanotechnology lab at the George Washington University, and is designed to integrate with healthy tissue over time, for maximum stability and benefit to the patient. Nanochon has the potential to deliver more successful and longer-lasting recovery for patients than current standard of care. Our mission is to develop a new approach to treat cartilage defects so that the hundreds of thousands of young, active patients with joint damage can return to their lifestyles without undergoing costly and invasive short-term fixes.

Florida attorney general identifies wrongful charges under halted immigration law
Florida attorney general identifies wrongful charges under halted immigration law

Yahoo

time35 minutes ago

  • Yahoo

Florida attorney general identifies wrongful charges under halted immigration law

ORLANDO, Fla. (AP) — At least two people have been wrongly charged under a Florida law that outlaws people living in the U.S. illegally from entering the state since a federal judge halted its enforcement, according to a report Florida's attorney general is required to file as punishment for defying the judge's ruling. Both men were arrested in late May by deputies in northeast Florida's St. Johns County, more than a month after U.S. District Judge Kathleen Williams in Miami issued an order freezing the enforcement of the state statute. The law makes it a misdemeanor for people who are in the U.S. without legal permission to enter Florida by eluding immigration officials. Florida Attorney General James Uthmeier said in his report filed at the beginning of July that he only became aware of the two cases at the end of June after requesting information from state and local law enforcement. As punishment for flouting her order and being found in contempt, the judge requires Uthmeier to file bimonthly reports about whether any arrests, detentions or law enforcement actions have been made under the law. On May 29, St. Johns County Sheriff's Office deputies arrested a man with an active immigration detainer from Immigration and Customs Enforcement and another man on counts of illegal entry and driving without a valid driver's license, according to the status report. As corrective action, the charge involving the man with the ICE detainer was dismissed in state court, and prosecutors filed a motion that was granted to vacate the charge for illegal entry in the second case, R.J. Larizza, state attorney for the jurisdiction that covers St. Johns County, said in a separate filing. Florida Gov. Ron DeSantis signed the legislation into law in February as part of President Donald Trump's crackdown on illegal immigration. Immigrants rights groups filed a lawsuit on behalf of two unnamed, Florida-based immigrants living in the U.S. illegally shortly after the bill was signed into law. The lawsuit said the new legislation violates the Supremacy Clause of the U.S. Constitution by encroaching on federal duties. Williams issued a temporary restraining order and injunction that barred the enforcement of the new law statewide in April. The attorney general's office then unsuccessfully petitioned the 11th Circuit Court of Appeals to override that decision. Uthmeier has petitioned the U.S. Supreme Court to review the case. After Williams issued her original order, Uthmeier sent a memo to state and local law enforcement officers telling them to refrain from enforcing the law, even though he disagreed with the injunction. But five days later, he sent a memo saying the judge was legally wrong and that he couldn't prevent police officers and deputies from enforcing the law. The judge last month found Uthmeier to be in civil contempt of her ruling. Besides championing the new law, Florida officials have helped Trump's immigration crackdown with the construction of a new immigration detention center named 'Alligator Alcatraz' at an isolated airstrip in the Florida Everglades. DeSantis said at a news conference Wednesday that a request has been developed for proposals for a second migrant detention facility at Camp Blanding in northeast Florida but no work has begun. Alligator Alcatraz has 'grown quickly' but is not yet at the 3,000 to 4,000 detainees originally envisioned, DeSantis said in Tampa. 'I'm willing to do Blanding once Alligator Alcatraz is filled,' the governor said. 'Once there's a demand, then we would be able to go for Camp Blanding.' ___ Associated Press journalist Curt Anderson in St. Petersburg, Florida, contributed to this report. ___ Follow Mike Schneider on the social platform Bluesky: @ Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store